Kepler Capital Sticks to Their Buy Rating for Bayer (0P6S)
Kepler Capital analyst Christian Faitz maintained a Buy rating on Bayer on February 17 and set a price target of €53.00. The company’s shares closed last Tuesday at €49.32.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Faitz is a 4-star analyst with an average return of 6.9% and a 51.48% success rate. Faitz covers the Basic Materials sector, focusing on stocks such as Wacker Chemie AG, Yara International, and K+S Aktiengesellschaft.
In addition to Kepler Capital , Bayer also received a Buy from Goldman Sachs’s James Quigley in a report issued yesterday. However, on the same day, DZ BANK AG downgraded Bayer (LSE: 0P6S) to a Sell.
0P6S market cap is currently €45.18B and has a P/E ratio of -228.21.
Read More on GB:0P6S:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.